IIL Stock Overview
A pharmaceutical company, engages in the production and distribution of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Intravenous Infusions Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | GH₵0.05 |
| 52 Week High | GH₵0 |
| 52 Week Low | GH₵0 |
| Beta | 0.45 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 25.00% |
| 33 Year Change | 0% |
| 5 Year Change | 0% |
| Change since IPO | -37.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| IIL | GH Pharmaceuticals | GH Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | 0.8% |
| 1Y | 25.0% | 0.8% | 46.2% |
Return vs Industry: IIL exceeded the GH Pharmaceuticals industry which returned 0.8% over the past year.
Return vs Market: IIL underperformed the GH Market which returned 46.2% over the past year.
Price Volatility
| IIL volatility | |
|---|---|
| IIL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 2.5% |
| 10% most volatile stocks in GH Market | 5.4% |
| 10% least volatile stocks in GH Market | 1.0% |
Stable Share Price: IIL's share price has been volatile over the past 3 months compared to the GH market.
Volatility Over Time: Insufficient data to determine IIL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | Moukhtar Soalihu | www.iil.com.gh |
Intravenous Infusions Plc, a pharmaceutical company, engages in the production and distribution of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. The company offers pethidine, which includes Chloroquine Phosphate and quinine dihydrochloride injections. Intravenous Infusions Plc was incorporated in 1969 and is based in Koforidua, Ghana.
Intravenous Infusions Plc Fundamentals Summary
| IIL fundamental statistics | |
|---|---|
| Market cap | GH₵13.72m |
| Earnings (TTM) | GH₵949.89k |
| Revenue (TTM) | GH₵30.46m |
14.4x
P/E Ratio0.5x
P/S RatioIs IIL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IIL income statement (TTM) | |
|---|---|
| Revenue | GH₵30.46m |
| Cost of Revenue | GH₵14.31m |
| Gross Profit | GH₵16.15m |
| Other Expenses | GH₵15.20m |
| Earnings | GH₵949.89k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0035 |
| Gross Margin | 53.02% |
| Net Profit Margin | 3.12% |
| Debt/Equity Ratio | 62.1% |
How did IIL perform over the long term?
See historical performance and comparison